In our study, LIMD1 overexpression in lung adenocarcinoma cells increased the sensitivity of lung adenocarcinoma cells to cisplatin, suggesting that LIMD1 is involved in regulating the susceptibility of lung cancer cells to this drug. The gene discussed is LIMD1; the disease is lung carcinoma.